Tekla Life Sciences Investors (HQL) has a market capitalization of $512.49M and trades at $17.75. The 52-week range is 10.55-17.8.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 6, Earnings Per Share (EPS) of $2.96, annual revenue of $86.39M.
The stock has a beta of 0.74, a last dividend of $1.9100, operates in the Financial Services sector.
